Eltoprazine: Clinical trial data

A double-blind trial in 25 evaluable elderly AD patients with dementia who are aggressive showed that oral eltoprazine reduced SDAS

Read the full 206 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE